Nexalin Technology (NXL) Change in Inventory (2021 - 2026)
Nexalin Technology's (NXL) quarterly Change in Inventory came in at $48016.0 in Q1 2026, up 7013.48% year-on-year from $675.0 in Q1 2025, and up 488.1% quarter-over-quarter from -$12372.0 in Q4 2025.
Nexalin Technology (NXL) Change in Inventory (2021 - 2026) Analysis & Trends
Nexalin Technology's Change in Inventory history runs 6 years deep, the most recent figure standing at $48016.0 for Q1 2026.
- On a quarterly basis, Change in Inventory rose 7013.48% year-over-year to $48016.0 in Q1 2026; TTM through Mar 2026 was $20616.0, a 4.49% decrease from a year earlier, with the FY2025 full-year figure at -$26725.0, down 247.18% from the prior year.
- Change in Inventory grew to $48016.0 in Q1 2026 per NXL's latest filing, from -$12372.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $48016.0 in Q1 2026 and bottomed at -$12749.0 in Q3 2025.
- The 5-year median for Change in Inventory is $3563.0 (2023), against an average of $11183.1.
- Across the five-year window, Change in Inventory plunged 590.9% in 2024 and surged 7013.48% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $22191.0 in 2022, then sank by 83.94% to $3563.0 in 2023, then surged by 354.76% to $16203.0 in 2024, then tumbled by 176.36% to -$12372.0 in 2025, then surged by 488.1% to $48016.0 in 2026.
- Per Business Quant, the three latest NXL Change in Inventory figures stand at $48016.0 (Q1 2026), -$12372.0 (Q4 2025), and -$12749.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 48,016.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,016.00 |
| Mar 31, 2026 | 48,016.00 |
| Dec 31, 2025 | -12,372.00 |
| Dec 31, 2025 | -12,372.00 |
| Sep 30, 2025 | -12,749.00 |
| Sep 30, 2025 | -12,749.00 |
| Jun 30, 2025 | -2,279.00 |
| Jun 30, 2025 | -2,279.00 |
| Mar 31, 2025 | 675.00 |
| Mar 31, 2025 | 675.00 |
| Dec 31, 2024 | 16,203.00 |
| Dec 31, 2024 | 16,203.00 |
| Sep 30, 2024 | 13,234.00 |
| Sep 30, 2024 | 13,234.00 |
| Jun 30, 2024 | -8,527.00 |
| Jun 30, 2024 | -8,527.00 |
| Mar 31, 2024 | -2,752.00 |
| Mar 31, 2024 | -2,752.00 |
| Dec 31, 2023 | 3,563.00 |
| Dec 31, 2023 | 3,563.00 |